Explore the detailed record of transactions filed by Gibson Christopher. Director active across 1 company, notably Recursion Pharmaceuticals, INC.. In total, 29 reports have been recorded. Activity tracked since 5 June 2026. The latest transaction was filed on 21 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Gibson Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Gibson Christopher is a former director of Recursion Pharmaceuticals, INC. (XNAS). He has 17 filings in total, and across the sampled recent filings from 2026-06-05 to 2026-07-21, they relate only to sales, for a total of EUR 6824834, with the most common transaction nature being a notice of proposed sale (Form 144).